Bedaquiline for the treatment of drug-resistant tuberculosis.
about
Management of drug resistantTB in patients with HIV co-infection.Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline.New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations.HT-SPOTi: A Rapid Drug Susceptibility Test (DST) to Evaluate Antibiotic Resistance Profiles and Novel Chemicals for Anti-Infective Drug Discovery.[Drug-resistant tuberculosis. Epidemiology, diagnostics and therapy].
P2860
Bedaquiline for the treatment of drug-resistant tuberculosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bedaquiline for the treatment of drug-resistant tuberculosis.
@en
type
label
Bedaquiline for the treatment of drug-resistant tuberculosis.
@en
prefLabel
Bedaquiline for the treatment of drug-resistant tuberculosis.
@en
P2093
P2860
P1476
Bedaquiline for the treatment of drug-resistant tuberculosis.
@en
P2093
Charlotte C Heuvelings
Sabine Bélard
Saskia Janssen
P2860
P304
P356
10.1586/14787210.2015.1021785
P577
2015-03-22T00:00:00Z